Stockreport

Acorda Has Suffered 2 Setbacks, Both Of Which Can Be Dealt With [Seeking Alpha]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Summary Acorda Therapeutics receives notice that its inhaled Parkinson's treatment Inbrija has been pushed back to January 5, 2019. Another setback came about w [Read more]